Literature DB >> 10069952

DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection.

J W Hooper1, K I Kamrud, F Elgh, D Custer, C S Schmaljohn.   

Abstract

Seoul virus (SEOV) is one of four known hantaviruses causing hemorrhagic fever with renal syndrome (HFRS). Candidate naked DNA vaccines for HFRS were constructed by subcloning cDNA representing the medium (M; encoding the G1 and G2 glycoproteins) or small (S; encoding the nucleocapsid protein) genome segment of SEOV into the DNA expression vector pWRG7077. We vaccinated BALB/c mice with three doses of the M or S DNA vaccine at 4-week intervals by either gene gun inoculation of the epidermis or needle inoculation into the gastrocnemius muscle. Both routes of vaccination resulted in antibody responses as measured by ELISA; however, gene gun inoculation elicited a higher frequency of seroconversion and higher levels of antibodies in individual mice. We vaccinated Syrian hamsters with the M or S construct using the gene gun and found hantavirus-specific antibodies in five of five and four of five hamsters, respectively. Animals vaccinated with the M construct developed a neutralizing antibody response that was greatly enhanced in the presence of guinea pig complement. Immunized hamsters were challenged with SEOV and, after 28 days, were monitored for evidence of infection. Hamsters vaccinated with M were protected from infection, but hamsters vaccinated with S were not protected.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069952     DOI: 10.1006/viro.1998.9586

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  44 in total

1.  Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice.

Authors:  Dominic Wichmann; Hermann-Josef Gröne; Michael Frese; Jovan Pavlovic; Bärbel Anheier; Otto Haller; Hans-Dieter Klenk; Heinz Feldmann
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 2.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

Review 3.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

4.  Hantavirus Gn and Gc glycoproteins self-assemble into virus-like particles.

Authors:  Rodrigo Acuña; Nicolás Cifuentes-Muñoz; Chantal L Márquez; Manuela Bulling; Jonas Klingström; Roberta Mancini; Pierre-Yves Lozach; Nicole D Tischler
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

5.  Maternally derived recombinant human anti-hantavirus monoclonal antibodies are transferred to mouse offspring during lactation and neutralize virus in vitro.

Authors:  Shuyang Yu; Mifang Liang; Baoliang Fan; Hongtao Xu; Chuan Li; Quanfu Zhang; Dexin Li; Bo Tang; Shijie Li; Yunping Dai; Meili Wang; Min Zheng; Bingxue Yan; Qinghong Zhu; Ning Li
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 6.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.

Authors:  Kyle S Brown; David Safronetz; Andrea Marzi; Hideki Ebihara; Heinz Feldmann
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

8.  Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.

Authors:  Victoria Wahl-Jensen; Jennifer Chapman; Ludmila Asher; Robert Fisher; Michael Zimmerman; Tom Larsen; Jay W Hooper
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.

Authors:  Rebecca L Brocato; Christopher D Hammerbeck; Todd M Bell; Jay B Wells; Laurie A Queen; Jay W Hooper
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.

Authors:  David Safronetz; Nagendra R Hegde; Hideki Ebihara; Michael Denton; Gary P Kobinger; Stephen St Jeor; Heinz Feldmann; David C Johnson
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.